Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Protocols in Toxicology|October 10, 2012
Measuring lymphocyte transcription factor activity by ELISAJesica McCue, Brian Freed
Plos One|April 5, 2013
Knockdown of HPRT for selection of genetically modified human hematopoietic progenitor cellsRashmi Choudhary, Dmitry Baturin, Susan Fosmire, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|March 28, 2013
Blinding measured: a systematic review of randomized controlled trials of acupunctureAlex Moroz, Brian Freed, Laura Tiedemann, et al.
Transfusion|September 7, 2016
How transplant centers deal with the dextran shortage: recommendations for comparing alternativesColleen Brady, Sue Armitage, Brian Freed, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 29, 2006
Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratificationEric M Gibney, Linda R Cagle, Brian Freed, et al.
Psychiatry Research|June 17, 2014
Assessing blinding in trials of psychiatric disorders: a meta-analysis based on blinding indexBrian Freed, Oliver Paul Assall, Gary Panagiotakis, et al.
Clinical Trials (London, England)|January 22, 2021
Blinding, sham, and treatment effects in randomized controlled trials for back pain in 2000-2019: A review and meta-analytic approachBrian Freed, Brian Williams, Xiaolu Situ, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 20, 2017
Lower tacrolimus exposure and time in therapeutic range increase the risk of de novo donor-specific antibodies in the first year of kidney transplantationScott Davis, Jane Gralla, Patrick Klem, et al.
Molecular Immunology|December 30, 2019
Complement fragments are biomarkers of antibody-mediated endothelial injuryErik Stites, Brandon Renner, Jennifer Laskowski, et al.
The Journal of Biological Chemistry|May 8, 2026
A Comprehensive Discovery Platform for ELOVL1 Small Molecule Inhibitors Targeting Very Long Chain Fatty Acid Synthesis in AdrenoleukodystrophyStephanie Holley, Gary Asmussen, Becky Lam, et al.
Pageof 2